These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9915099)

  • 41. Issues related to monitoring the safety of over-the-counter (OTC) medicines.
    Bond C; Hannaford P
    Drug Saf; 2003; 26(15):1065-74. PubMed ID: 14640771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginitis: making sense of over-the-counter treatment options.
    Angotti LB; Lambert LC; Soper DE
    Infect Dis Obstet Gynecol; 2007; 2007():97424. PubMed ID: 18253469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly?
    Francis SA; Barnett N; Denham M
    Drugs Aging; 2005; 22(5):361-70. PubMed ID: 15903349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Issues and Prospects from the OTC Industry vis a vis Pharmaceutical Education and OTC Medicines].
    Nishizawa M
    Yakugaku Zasshi; 2016; 136(7):955-63. PubMed ID: 27374957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC; Bohn RL; Avorn J
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.
    Roy S; Caillouette JC; Faden JS; Roy T; Ramos DE
    Infect Dis Obstet Gynecol; 2003; 11(4):209-16. PubMed ID: 15108867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of the reclassification of drugs from prescription-only to over-the-counter status.
    Gossel TA
    Clin Ther; 1991; 13(2):200-15; discussion 199. PubMed ID: 1863936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
    Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
    Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns.
    Sihvo S; Ahonen R; Mikander H; Hemminki E
    Fam Pract; 2000 Apr; 17(2):145-9. PubMed ID: 10758077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-medication and non-prescription drug counseling: Illustrating profession uncertainty within Turkish pharmacy practice.
    Cavaco AM; Sozen-Sahne B; Ulutas-Deniz E; Yegenoglu S
    Res Social Adm Pharm; 2018 Aug; 14(8):718-726. PubMed ID: 29017755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals.
    Mathema B; Cross E; Dun E; Park S; Bedell J; Slade B; Williams M; Riley L; Chaturvedi V; Perlin DS
    Clin Infect Dis; 2001 Sep; 33(5):E23-7. PubMed ID: 11477529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abuse of prescription and over-the-counter medications.
    Lessenger JE; Feinberg SD
    J Am Board Fam Med; 2008; 21(1):45-54. PubMed ID: 18178702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Over the counter treatment for candidiasis.
    Mitchell S; Bradbeer C
    BMJ; 1992 Jun; 304(6843):1648. PubMed ID: 1633516
    [No Abstract]   [Full Text] [Related]  

  • 56. New OTC drugs and devices 1999: a selective review.
    Newton GD; McCullough JA; Pray WS; Popovich NG
    J Am Pharm Assoc (Wash); 2000; 40(2):222-33. PubMed ID: 10730023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How the elderly and young adults differ in the decision making process of nonprescription medication purchases.
    Sansgiry SS; Cady PS
    Health Mark Q; 1996; 14(1):3-21. PubMed ID: 10163023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The purchase decision process and involvement of the elderly regarding nonprescription products.
    Reisenwitz TH; Wimbish GJ
    Health Mark Q; 1997; 15(1):49-68. PubMed ID: 10179064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consumer behavior in the setting of over-the-counter statin availability: lessons from the consumer use study of OTC Mevacor.
    Brass EP
    Am J Cardiol; 2004 Nov; 94(9A):22F-29F. PubMed ID: 15519288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consumers' preference and willingness to pay for pharmacist counselling for non-prescription medicines.
    Gore PR; Madhavan S
    J Clin Pharm Ther; 1994 Feb; 19(1):17-25. PubMed ID: 8188784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.